This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Black widow spider antivenin (equine)
- DrugBank Accession Number
- DB14113
- Background
Black widow spider (Latrodectus mactans) antivenin is a treatment for black widow spider bites derived from the serum of healthy horses immunized against black widow spider venom.1
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Protein Based Therapies
Other protein based therapies - Protein Chemical Formula
- Not Available
- Protein Average Weight
- Not Available
- Sequences
- Not Available
- Synonyms
- Antivenin (latrodectus mactans)
- Antivenin (latrodectus mactans) (equine)
- Antivenin, latrodectus mactans
- Antivenin, latrodectus mactans, equine
- Antivenin,latrodectus mactans
- Black widow spider (latrodectus mactans) antivenin
- Black widow spider (latrodectus mactans) immune antivenin (equine)
- BLACK WIDOW SPIDER (LATRODECTUS MACTANS) IMMUNE FAB2 ANTIVENIN (EQUINE)
- Black widow spider (latrodectus mactans) immune globulin antivenin (equine)
- Black widow spider (latrodectus mactans) immune globulin(equine)
- Black widow spider (latrodectus mactans) immunoglobulin(equine)
- Black widow spider antivenom
- LATRODECTUS IMMUNE F(AB)2
- Latrodectus mactans antivenin
- Southern black widow spider antivenin
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Antivenin Injection, powder, lyophilized, for solution; Kit 6000 [iU]/2.5mL Intramuscular; Intravenous Merck Sharp & Dohme Llc 2014-12-01 Not applicable US 
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Antivenin Black widow spider antivenin (equine) (6000 [iU]/2.5mL) + Serum, horse (1 mL/1mL) + Water (2.5 mL/2.5mL) Kit Conjunctival; Intradermal; Intramuscular; Intravenous Merck Sharp & Dohme Corp. 1947-05-14 2010-12-06 US
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- Not Available
- Kingdom
- Organic Compounds
- Super Class
- Organic Acids
- Class
- Carboxylic Acids and Derivatives
- Sub Class
- Amino Acids, Peptides, and Analogues
- Direct Parent
- Peptides
- Alternative Parents
- Not Available
- Substituents
- Not Available
- Molecular Framework
- Not Available
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- APK07X226X
- CAS number
- Not Available
References
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, powder, lyophilized, for solution; kit Intramuscular; Intravenous 6000 [iU]/2.5mL Kit Conjunctival; Intradermal; Intramuscular; Intravenous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at June 22, 2018 20:17 / Updated at October 19, 2023 10:36